A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...